1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
Poster Session
MM - 768
Net Costs Associated With Inpatient Administration of Step-Up Dosing (SUD) of Bispecific Antibodies (bsAbs) Among Medicare Patients With Relapsed/Refractory Multiple Myeloma (MM)
Timothy Inocencio
Poster Presenter: Timothy Inocencio
MM - 770
Ciltacabtagene Autoleucel in Lenalidomide-Refractory Multiple Myeloma Responding to Bridging Therapy: CARTITUDE-4 Cytogenetic Subgroup Analysis
Roberto Mina
Poster Presenter: Roberto Mina
MM - 780
Updated Results From the Phase 2 IZALCO Study: Efficacy and Safety of Isatuximab Subcutaneous Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Wanda Vila-Carriles
Poster Presenter: Wanda Vila-Carriles
MM - 785
Rising Venous Thromboembolism-Associated Mortality Despite Declining Overall Multiple Myeloma Mortality in the United States, 1999-2024: Pulmonary Embolism Burden and Demographic Disparities
Ayse Gul Korkmaz
Poster Presenter: Ayse Gul Korkmaz
MM - 795
Treatment-Limiting On-Target Toxicity With Talquetamab/GPRC5D-Directed Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
Ayse Gul Korkmaz
Poster Presenter: Ayse Gul Korkmaz
MM - 803
Correlation Between Mobilization Regimen and CD34? Stem Cell Yield in Multiple Myeloma (MM) Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT): A Single-Center Retrospective Analysis
Solomiia Hlukhovska
Poster Presenter: Solomiia Hlukhovska
MM - 813
Generalizability Gaps in BCMA- and GPRC5D-Directed Immunotherapy Trials for Relapsed/Refractory Multiple Myeloma: A Trial-Level Eligibility Analysis
Ayse Gul Korkmaz
Poster Presenter: Ayse Gul Korkmaz
